Latest Risperdal Case Developments: New Study, Start of Bellwether Trial, $2.2 Billion Settlement

With 900 pending Multi-District Litigation cases in Philadelphia, the first bellwether trial concerning Risperdal’s side effects started on Monday. The Nov. 3 trial (Re: Risperdal Litigation, Case No: 100300296, in the Philadelphia Court of Common Pleas) is the start of three to determine how the jury will respond. The second has been scheduled for January…

Read More

Risperdal’s Side Effects: Range and Severity

Risperdal, an atypical antipsychotic approved for treatment of bipolar disorder and schizophrenia in adults and autism and bipolar disorder in children, has been the subject of multiple lawsuits at the state level. Plaintiffs claim manufacturer Johnson & Johnson never provided sufficient warning about side effects, and stated false claims concerning risks in advertising. As well,…

Read More